Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)
Hong Kong · Delayed Price · Currency is HKD 1.535
+0.060 (4.07%)
Sep 21, 2026, 11:28 AM HKT
HKG:2185 Market Cap
HKG:2185 has a market cap or net worth of 359.04 million as of September 18, 2026. Its market cap has decreased by -79.93% in one year.
Market Cap
359.04M
Enterprise Value
301.73M
Revenue
44.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.54
ChartMarket Cap Chart
Since December 23, 2021, HKG:2185's market cap has decreased from 4.90B to 359.04M, a decrease of -92.68%. That is a compound annual growth rate of -42.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 359.04M | -74.53% |
| Dec 31, 2025 | 1.41B | 253.05% |
| Dec 31, 2024 | 399.20M | -52.05% |
| Dec 29, 2023 | 832.49M | -41.56% |
| Dec 30, 2022 | 1.42B | -78.41% |
| Dec 31, 2021 | 6.60B | 34.58% |
| Dec 23, 2021 | 4.90B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kintor Pharmaceutical | 898.73M |
| JW (Cayman) Therapeutics Co. | 892.97M |
| Wuhan YZY Biopharma | 639.70M |
| Brii Biosciences | 638.80M |
| 3D Medicines | 607.42M |
| B&K Corporation | 470.63M |
| Cutia Therapeutics | 436.04M |
| Uni-Bio Science Group | 435.90M |